C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.
Shuo Lin , Dario Rusciano , Patrizia Lorenzoni , Guido Hartmann
Clinical & Experimental Metastasis 16 ( 3) 253 -265
17
1998
Activation of RAS family members confers resistance to ROS1 targeting drugs.
Marilisa Cargnelutti , Simona Corso , Margherita Pergolizzi , Laurence Mévellec
Oncotarget 6 ( 7) 5182 -5194
60
2015
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
Annalisa Petrelli , Rosachiara Carollo , Marilisa Cargnelutti , Flora Iovino
Oncotarget 6 ( 4) 2315 -2330
33
2015
Targeting Plasmodium host cells: survival within hepatocytes
Maria M. Mota , Silvia Giordano , Ana Rodriguez
Trends in Molecular Medicine 10 ( 10) 487 -492
5
2004
Cancer therapy: can the challenge be MET?
Simona Corso , Paolo M. Comoglio , Silvia Giordano
Trends in Molecular Medicine 11 ( 6) 284 -292
321
2005
Resistance to targeted therapies: a role for microRNAs?
Cristina Migliore , Silvia Giordano
Trends in Molecular Medicine 19 ( 10) 633 -642
22
2013
The Dual Roles of NRF2 in Cancer
Silvia Menegon , Amedeo Columbano , Silvia Giordano
Trends in Molecular Medicine 22 ( 7) 578 -593
530
2016
How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
Simona Corso , Silvia Giordano
Trends in Molecular Medicine 22 ( 7) 534 -544
38
2016
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis
Patrizia Zavattari , Andrea Perra , Silvia Menegon , Marta Anna Kowalik
Hepatology 62 ( 3) 851 -862
55
2015
The landscape of d16HER2 splice variant expression across HER2-positive cancers.
Chiara Costanza Volpi , Filippo Pietrantonio , Annunziata Gloghini , Giovanni Fucà
Scientific Reports 9 ( 1) 3545 -3556
11
2019
Plexin‐B3 is a functional receptor for semaphorin 5A
Stefania Artigiani , Paolo Conrotto , Pietro Fazzari , Giorgio F Gilestro
EMBO reports 5 ( 7) 710 -714
119
2004
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
Marta Anna Kowalik , Giulia Guzzo , Andrea Morandi , Andrea Perra
Oncotarget 7 ( 22) 32375 -32393
54
2016
Targeting MET: why, where and how?
Elena Ghiso , Silvia Giordano
Current Opinion in Pharmacology 13 ( 4) 511 -518
41
2013
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
Elena Ghiso , Cristina Migliore , Vito Ciciriello , Elena Morando
Neoplasia 19 ( 12) 1012 -1021
32
2017
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts
Simona Corso , Marilisa Cargnelutti , Stefania Durando , Silvia Menegon
Neoplasia 20 ( 5) 443 -455
8
2018
MiRNAs as new master players.
Cristina Migliore , Silvia Giordano
Cell Cycle 8 ( 14) 2185 -2186
8
2009
Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
Claudia Orrù , Silvia Giordano , Amedeo Columbano
Cancers 12 ( 10) 2932
13
2020
Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
Michela Camilla Milanesio , Silvia Giordano , Giorgio Valabrega
Cancers 12 ( 5) 1315
4
2020
Autocrine signaling of NRP1 ligand galectin-1 elicits resistance to BRAF-targeted therapy in melanoma cells
Sabrina Rizzolio , Simona Corso , Silvia Giordano , Luca Tamagnone
Cancers 12 ( 8) 2218
1
2020
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis.
Claudia Orrù , Andrea Perra , Marta Anna Kowalik , Sabrina Rizzolio
Cancers 12 ( 8) 2305
7
2020